Phathom Pharmaceuticals Inc
PHAT
$8.77-0.34%
End of day · as of Aug 26, 2026, 4:09 PM ET
Mkt cap
$622.74M
EV/Sales
4.01
P/E ratio
N/A
FY2025 Revenue
$175.11M
EPS (TTM)
$-1.25
Gross Margin (FY2025)
87.09%
Profit Margin (FY2025)
-126.35%
Beta
0.10
Div yield
N/A
Sector
Healthcare
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported PHAT revenue for 2025-12-31 was $175.1M. Net income was -$221.2M. Revenue was up 216.9% from 2024-12-31 to 2025-12-31. PHAT currently screens at market cap $622.7M.
Use this PHAT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PHAT income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company in the Healthcare sector.
Latest cached Phathom Pharmaceuticals Inc (PHAT) revenue for Dec 31, 2025 was $175.1M. Net income was -$221.2M. Statements: https://lician.com/financials/phat
Phathom Pharmaceuticals Inc (PHAT) market capitalization is $622.7M on the latest cached snapshot.
Phathom Pharmaceuticals Inc (PHAT) cached previous close $8.80; day range $8.57 – $8.86; volume 588,434. Session quote: https://lician.com/quote/phat
Phathom Pharmaceuticals Inc (PHAT) latest cached earnings event is "PHAT earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PHAT filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/phat